Hold GLP-1s Before Endoscopy? Clinical Trial Finds Retained Gastric ContentsHold GLP-1s Before Endoscopy? Clinical Trial Finds Retained Gastric Contents
(MedPage Today) — Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume (RGV) if the medication wasn’t held prior to upper endoscopy unless they were on a clear liquid diet the day before, the OCULUS randomized trial… (MedPage Today) — Patients on GLP-1 or GLP-1/GIP agonists had significant residual gastric volume (RGV) Read More
Trump chief of staff Susie Wiles diagnosed with breast cancerTrump chief of staff Susie Wiles diagnosed with breast cancer
Wiles, 68, praised by president as ‘one of the strongest people I know’, to continue working while having treatmentSusie Wiles, the first woman to serve as White House chief of staff, has been diagnosed with early-stage breast cancer but plans to continue working while undergoing treatment.The 68-year-old revealed on Monday that the illness had been detected in the past week. Both she and Donald Trump struck an optimistic tone, saying doctors expect a strong recovery. Continue reading…
Trump’s White House chief of staff Susie Wiles diagnosed with breast cancerTrump’s White House chief of staff Susie Wiles diagnosed with breast cancer
Wiles will continue to work “virtually full time at the White House” while undergoing treatment, the US president said.
Trump says chief of staff Susie Wiles has been diagnosed with breast cancerTrump says chief of staff Susie Wiles has been diagnosed with breast cancer
President Trump announced that White House chief of staff Susie Wiles has been diagnosed with breast cancer but will remain in her role as she receives treatment.
Trump says chief of staff Susie Wiles was diagnosed with early stage breast cancerTrump says chief of staff Susie Wiles was diagnosed with early stage breast cancer
President Trump announced Monday on social media that his chief of staff, Susie Wiles, was diagnosed with early stage breast cancer. Mr. Trump also said Wiles would continue to work full time. CBS News’ Weijia Jiang has more.
WH chief of staff Susie Wiles diagnosed with early stage breast cancer, prognosis ‘excellent,’ Trump saysWH chief of staff Susie Wiles diagnosed with early stage breast cancer, prognosis ‘excellent,’ Trump says
White House chief of staff Susie Wiles has been diagnosed with early-stage breast cancer and will begin treatment immediately, President Donald Trump said Monday.Trump said Wiles has an “excellent” prognosis and plans to continue working at the White House while undergoing treatment.”Her Strength and her Commitment to continue doing the job she loves, and does so well, while undergoing treatment, tells you everything you need to know about her. Susie, as one of my closest and most important advisors, is tough and deeply committed to serving the American People,” the president wrote on his Truth Social account.”She will soon be better than ever! Melania and I are with her in every way, and we look forward to working with Susie on the many big and wonderful things that are happening for the benefit of our Country!”This is a breaking news story; check back for updates.
White House chief of staff Susie Wiles diagnosed with breast cancer, Trump saysWhite House chief of staff Susie Wiles diagnosed with breast cancer, Trump says
President Trump said White House chief of staff Susie Wiles will “continue doing the job she loves” even while undergoing treatment for early stage breast cancer.
White House chief of staff Susie Wiles diagnosed with breast cancer, Trump saysWhite House chief of staff Susie Wiles diagnosed with breast cancer, Trump says
WASHINGTON — White House chief of staff Susie Wiles was diagnosed with “early stage” breast cancer, President Donald Trump said Monday
STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pillSTAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
Structure Therapeutics said Monday that its daily obesity pill led patients to lose about 16% of their body weight relative to placebo after 44 weeks. The results of the Phase 2 study could position the company to compete against Eli Lilly and Novo Nordisk in a high-stakes race to develop oral versions of blockbuster GLP-1 Read More
Martha Stewart’s cardiologist says a simple smoothie add-in is like ‘taking Ozempic’Martha Stewart’s cardiologist says a simple smoothie add-in is like ‘taking Ozempic’
Martha Stewart says her cardiologist compared a simple smoothie add-in to “taking Ozempic” — and now she uses it every day. The lifestyle icon revealed on a recent episode of her podcast that her cardiologist recommended beetroot powder, which she described as beneficial for cardiovascular health and weight loss. “You lose weight with it,” Stewart Read More